CLAIM #2541 · AbbVie Inc (ABBV) · 2024Q4 earnings call · Jan 31, 2025 · due Dec 31, 2025
“And then we expect the international business to continue to increase as a percent of the revenue for overall global Allergan aesthetics.”
Carrie Strom · President, Global Allergan Aesthetics
PENDING
graded after results covering Dec 31, 2025 are reported
Verify independently
SEC filings for ABBV ↗ · Claim quote is verbatim from the 2024Q4 earnings call.